PVLA
Palvella Therapeutics
PVLA
PVLA
41 hedge funds and large institutions have $143M invested in Palvella Therapeutics in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
24% more funds holding
Funds holding: 33 → 41 (+8)
9.72% more ownership
Funds ownership: 35.95% → 45.66% (+9.7%)
Holders
41
Holding in Top 10
2
Calls
$56K
Puts
$2K
Top Buyers
| 1 | +$7.55M | |
| 2 | +$5.43M | |
| 3 | +$4.82M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.56M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.2M |
Top Sellers
| 1 | -$3.07M | |
| 2 | -$1.74M | |
| 3 | -$787K | |
| 4 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$506K |
| 5 |
Renaissance Technologies
New York
|
-$171K |
